SPDR S&P PHARMACEUTICALS ETF (XPH) Institutional Ownership Changes & 13F Activity

SPDR S&P PHARMACEUTICALS ETF (XPH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Morgan Stanley, Envestnet Asset Management Inc, Quadrature Capital Ltd, Wells Fargo & Company/Mn, and Teucrium Investment Advisors, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Envestnet Asset Management IncBuy+166,879+75.2%388,701$25.27MQ3 2026Nov 16, 2026
Wells Fargo & Company/MnBuy+45,285+11.7%432,653$28.12MQ3 2026Nov 16, 2026
Teucrium Investment Advisors, LlcBuy+44,177—44,177$2.87MQ3 2026Nov 16, 2026
Bank Of America CorpBuy+38,041+3.7%1,053,935$68.51MQ3 2026Nov 16, 2026
Royal Bank Of CanadaBuy+35,320+161.2%57,237$3.72MQ3 2026Nov 16, 2026
Gts Securities LlcSell-17,758-66.1%9,127$593.25KQ3 2026Nov 16, 2026
Garden State Investment Advisory Services LlcBuy+14,310—14,310$930.15KQ3 2026Nov 16, 2026
Goldman Sachs Group IncBuy+12,347+47.1%38,578$2.51MQ3 2026Nov 16, 2026
Clark Capital Management Group, Inc.Sell-10,186-30.9%22,743$1.48MQ3 2026Nov 16, 2026
Susquehanna International Group, LlpBuy+8,805+27.5%40,817$2.65MQ3 2026Nov 16, 2026
D. E. Shaw & Co., Inc.Buy+6,253+54.8%17,669$1.15MQ3 2026Nov 16, 2026
Millennium Management LlcBuy+3,727—3,727$242.25KQ3 2026Nov 16, 2026
&PartnersBuy+3,598—3,598$233.90KQ3 2026Nov 16, 2026
Beacon Pointe Advisors, LlcBuy+1,524+26.6%7,255$471.60KQ3 2026Nov 16, 2026
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LlcBuy+640—640$41.60KQ3 2026Nov 16, 2026
Ameriflex Group, Inc.Buy+400—400$26.00KQ3 2026Nov 16, 2026
Strategic Financial Concepts, LlcBuy+129—129$8.38KQ3 2026Nov 16, 2026
Vista Investment ManagementSell-102-2.6%3,884$252.46KQ3 2026Nov 16, 2026
Corient Private Wealth LlcBuy+4+0.1%3,405$221.32KQ3 2026Nov 16, 2026
Cohen & Steers, Inc.Buy+2—2$0.00Q3 2026Nov 16, 2026
Morgan StanleyBuy+216,946+69.0%531,172$34.53MQ3 2026Nov 13, 2026
Quadrature Capital LtdBuy+61,576—61,576$4.00MQ3 2026Nov 13, 2026
Kingsview Wealth Management, LlcSell-29,688-9.4%285,206$18.54MQ3 2026Nov 13, 2026
Qube Research & Technologies LtdBuy+17,742+7713.9%17,972$1.17MQ3 2026Nov 13, 2026
Cetera Investment AdvisersBuy+14,494+29.6%63,498$4.13MQ3 2026Nov 13, 2026
Rockefeller Capital Management L.P.Buy+9,029+47.9%27,892$1.81MQ3 2026Nov 13, 2026
V2 Financial Group LlcBuy+3,200—3,200$208.00KQ3 2026Nov 13, 2026
Northwestern Mutual Wealth Management CoBuy+2,144—2,144$139.36KQ3 2026Nov 13, 2026
Mml Investors Services, LlcSell-2,059-10.3%17,913$1.16MQ3 2026Nov 13, 2026
Baird Financial Group, Inc.Sell-1,938-6.8%26,530$1.72MQ3 2026Nov 13, 2026
Showing 30 of 103

Frequently asked questions about XPH activity

  • Which institutional owners are buying XPH?

    Institutional owners buying XPH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in XPH activity?

    "Buy" means an investor increased their reported position in XPH compared to the prior reporting period. This reflects growing exposure to SPDR S&P PHARMACEUTICALS ETF (XPH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in XPH increasing?

    Institutional interest in XPH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.